- Home
- ATOS vs USGO Comparison
ATOS vs USGO Comparison
Compare ATOS & USGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- USGO
- Stock Information
- Founded
- ATOS 2009
- USGO 2015
- Country
- ATOS United States
- USGO United States
- Employees
- ATOS N/A
- USGO N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- USGO Precious Metals
- Sector
- ATOS Health Care
- USGO Basic Materials
- Exchange
- ATOS Nasdaq
- USGO Nasdaq
- Market Cap
- ATOS 112.5M
- USGO 117.3M
- IPO Year
- ATOS 2012
- USGO 2023
- Fundamental
- Price
- ATOS $0.85
- USGO $8.25
- Analyst Decision
- ATOS Strong Buy
- USGO Strong Buy
- Analyst Count
- ATOS 3
- USGO 1
- Target Price
- ATOS $6.17
- USGO $26.50
- AVG Volume (30 Days)
- ATOS 1.5M
- USGO 36.9K
- Earning Date
- ATOS 08-11-2025
- USGO 08-12-2025
- Dividend Yield
- ATOS N/A
- USGO N/A
- EPS Growth
- ATOS N/A
- USGO N/A
- EPS
- ATOS N/A
- USGO N/A
- Revenue
- ATOS N/A
- USGO N/A
- Revenue This Year
- ATOS N/A
- USGO N/A
- Revenue Next Year
- ATOS N/A
- USGO N/A
- P/E Ratio
- ATOS N/A
- USGO N/A
- Revenue Growth
- ATOS N/A
- USGO N/A
- 52 Week Low
- ATOS $0.55
- USGO $5.00
- 52 Week High
- ATOS $1.66
- USGO $14.46
- Technical
- Relative Strength Index (RSI)
- ATOS 51.17
- USGO 39.64
- Support Level
- ATOS $0.81
- USGO $8.09
- Resistance Level
- ATOS $0.92
- USGO $8.78
- Average True Range (ATR)
- ATOS 0.05
- USGO 0.43
- MACD
- ATOS -0.00
- USGO -0.11
- Stochastic Oscillator
- ATOS 52.73
- USGO 27.15
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About USGO U.S. GoldMining Inc. Common stock
US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.